Q3 Earnings Forecast for Nukkleus Issued By Noble Financial

Nukkleus Inc. (NASDAQ:DFNSFree Report) – Analysts at Noble Financial boosted their Q3 2026 EPS estimates for shares of Nukkleus in a research note issued to investors on Wednesday, September 2nd. Noble Financial analyst J. Gomes now expects that the company will post earnings of ($1.70) per share for the quarter, up from their prior forecast of ($2.16). Noble Financial has a “Strong-Buy” rating on the stock. The consensus estimate for Nukkleus’ current full-year earnings is ($3.90) per share. Noble Financial also issued estimates for Nukkleus’ Q4 2026 earnings at ($1.11) EPS and FY2027 earnings at ($4.71) EPS.

Nukkleus (NASDAQ:DFNSGet Free Report) last issued its quarterly earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.11) by ($170.69). The firm had revenue of $4.00 million during the quarter, compared to the consensus estimate of $4.50 million.

Several other analysts also recently weighed in on the company. Weiss Ratings downgraded Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. Wall Street Zen raised Nukkleus from a “strong sell” rating to a “sell” rating in a research report on Sunday, August 23rd. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.

Read Our Latest Stock Analysis on Nukkleus

Nukkleus Trading Up 9.9%

Nukkleus stock opened at $10.18 on Friday. Nukkleus has a 52 week low of $3.70 and a 52 week high of $1,948.75. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.11 and a current ratio of 0.14. The firm has a market capitalization of $16.90 million, a PE ratio of -0.03 and a beta of -5.88. The business’s 50-day simple moving average is $22.53 and its 200-day simple moving average is $73.31.

Institutional Trading of Nukkleus

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. GM Advisory Group LLC acquired a new position in shares of Nukkleus during the fourth quarter valued at about $56,000. BNP Paribas Financial Markets acquired a new stake in Nukkleus during the second quarter worth about $56,000. Price T Rowe Associates Inc. MD bought a new position in Nukkleus during the fourth quarter valued at about $57,000. Millennium Management LLC bought a new position in Nukkleus during the fourth quarter valued at about $60,000. Finally, State Street Corp raised its holdings in Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after acquiring an additional 7,400 shares in the last quarter. 12.47% of the stock is currently owned by institutional investors and hedge funds.

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Recommended Stories

Earnings History and Estimates for Nukkleus (NASDAQ:DFNS)

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.